Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydroquinoxaline urea derivatives as modulators of 11β-hydroxysteroid dehydrogenase type 1

Tetrahydroquinoxaline urea derivatives as modulators of 11β-hydroxysteroid dehydrogenase type 1

US Patent 8530473 · Granted Sep 10, 2013

Estimated economic value: $12,039,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Acrylamide-substituted indane compounds and therapeutic use thereof2025
Ethynyl compounds, their preparation and their therapeutic use for the treatment2021
Oxindole derivatives, preparation thereof and therapeutic use in the treatment o2018
Oxindole derivatives, preparation thereof and therapeutic use in the treatment o2018
Oxindole derivatives, preparation thereof and therapeutic use in the treatment o2018
Pyrimidooxazocine derivatives as mTOR-inhibitors2015
Pyrimidooxazocine derivatives as mTOR-inhibitors2015
Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use 2013
Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use 2013
Tetrahydroquinoxaline urea derivatives as modulators of 11-B-hydroxysteroid dehy2013
Tetrahydroquinoxaline urea derivatives as modulators of 11-B-hydroxysteroid dehy2013
Tropane urea derivatives, preparation thereof and therapeutic application thereo2013